Clinical Trial Update: Safety of Aerius Syrup in Pediatric Patients Aged 1-5 Years Old With Allergic Rhinitis or Chronic Idiopathic Urticaria (Study P04446AM1)(COMPLETED)

View source ↗

Summary

A completed pediatric safety study of Aerius syrup in children 1-5 years with allergic rhinitis or chronic idiopathic urticaria; results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Urticaria

Drugs mentioned

• Aerius (cetirizine)

Snippet

Sponsor: Organon and Co | Conditions: Rhinitis, Urticaria | Status: COMPLETED | Results posted: 2009-08-06